Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Molecular Carcinogenesis

Hypoxia‐Induced ADAM23 Drives Neuron–Tumor Crosstalk and Therapeutic Resistance in Hepatocellular Carcinoma

  1. 1Division of Life Sciences, College of Life Science and Bioengineering Incheon National University Incheon Republic of Korea
  2. 2Institute for New Drug Development, College of Life Science and Bioengineering Incheon National University Incheon Republic of Korea

Abstract

Hypoxia and nutrient deprivation are fundamental drivers of tumor aggressiveness and therapeutic resistance in hepatocellular carcinoma (HCC). While the involvement of neural components in the tumor microenvironment (TME) is increasingly recognized, the molecular transducers linking metabolic stress to neuron–tumor crosstalk remain elusive. Here, we identify ADAM23 (A disintegrin and metalloproteinase 23) as a hypoxia‐responsive mediator that mediates communication between HCC cells and neuronal cells. ADAM23 expression was markedly upregulated in HCC cells under both chemical (CoCl2) and physical hypoxia (1% O2), a process further amplified by glucose deprivation and directly modulated by HIF‐1α. Functional assays revealed that ADAM23 overexpression promotes epithelial–mesenchymal transition (EMT) and enhances cell viability under metabolic stress. Notably, sorafenib‐resistant HCC cells (Huh7SR) exhibited high levels of ADAM23 secretion, which triggered proliferative and metabolic activation in neuronal SH‐SY5Y cells. In 3D co‐culture spheroid models, Huh7SR cells mixed with SH‐SY5Y cells displayed significantly larger spheroid volumes and enhanced neuronal fluorescence compared with parental controls, suggesting that ADAM23‐mediated interactions facilitate a supportive neural niche. Analysis of The Cancer Genome Atlas (TCGA) datasets and patient microarrays confirmed that ADAM23 is significantly overexpressed in HCC and positively correlates with HIF‐1α expression. Moreover, elevated expression of ADAM23 was significantly correlated with poor overall survival. Collectively, our findings underscore ADAM23 as a critical metabolic‐neural linker that promotes HCC progression and drug resistance. These findings suggest that the ADAM23‐mediated neuron–tumor axis may represent a potential therapeutic target in aggressive HCC.

Related

  1. CD36-Mediated Lipid Metabolic Reprogramming in Hepatocellular Carcinoma: Crosstalk With Immunity, Ferroptosis, and Therapeutic Resistance.
    Ankit Kumar Bijaraniya, Tao Lide
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Targeting Ferroptosis-Mediated Tumor Microenvironment Remodeling in Hepatocellular Carcinoma: Therapeutic Resistance and Clinical Translation
    Hong Liu, Xiaoying Zhang, Jianfeng Bao +3
    Journal of Hepatocellular CarcinomaPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  3. Portal Vein Tumor Thrombus in Hepatocellular Carcinoma: An Immune Sanctuary Driving Immune Exclusion and Therapeutic Resistance.
    Xingfei Li, Qian Cheng, Jiye Zhu +4
    Liver cancerPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Hepatic stellate cells drive hypoxia-inducible factor (HIF)-dependent metabolic rewiring and proliferation in hepatocellular carcinoma cells
    D. J. Rijlaarsdam, J.-C. Chang, J. B. Helms +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma.
    Wenhao Hu, Dute Gao, Guojun Hou +4
    Journal of hepatocellular carcinomaPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@article{park2026hypoxiainduced,
  title = {{Hypoxia‐Induced ADAM23 Drives Neuron–Tumor Crosstalk and Therapeutic Resistance in Hepatocellular Carcinoma}},
  author = {Taehyun Park and Soeun Kim and Hyunjung Cho and Johyeon Nam and Dayoung Choi and Misu Lee},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  month = sep,
  doi = {10.1002/mc.70174},
  url = {https://doi.org/10.1002/mc.70174},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Hypoxia‐Induced ADAM23 Drives Neuron–Tumor Crosstalk and Therapeutic Resistance in Hepatocellular Carcinoma
AU  - Taehyun Park
AU  - Soeun Kim
AU  - Hyunjung Cho
AU  - Johyeon Nam
AU  - Dayoung Choi
AU  - Misu Lee
PY  - 2026
DA  - 2026/09/03
JO  - Molecular Carcinogenesis
DO  - 10.1002/mc.70174
UR  - https://doi.org/10.1002/mc.70174
AB  - Hypoxia and nutrient deprivation are fundamental drivers of tumor aggressiveness and therapeutic resistance in hepatocellular carcinoma (HCC). While the involvement of neural components in the tumor microenvironment (TME) is increasingly recognized, the molecular transducers linking metabolic stress to neuron–tumor crosstalk remain elusive. Here, we identify ADAM23 (A disintegrin and metalloproteinase 23) as a hypoxia‐responsive mediator that mediates communication between HCC cells and neuronal cells. ADAM23 expression was markedly upregulated in HCC cells under both chemical (CoCl2) and physical hypoxia (1% O2), a process further amplified by glucose deprivation and directly modulated by HIF‐1α. Functional assays revealed that ADAM23 overexpression promotes epithelial–mesenchymal transition (EMT) and enhances cell viability under metabolic stress. Notably, sorafenib‐resistant HCC cells (Huh7SR) exhibited high levels of ADAM23 secretion, which triggered proliferative and metabolic activation in neuronal SH‐SY5Y cells. In 3D co‐culture spheroid models, Huh7SR cells mixed with SH‐SY5Y cells displayed significantly larger spheroid volumes and enhanced neuronal fluorescence compared with parental controls, suggesting that ADAM23‐mediated interactions facilitate a supportive neural niche. Analysis of The Cancer Genome Atlas (TCGA) datasets and patient microarrays confirmed that ADAM23 is significantly overexpressed in HCC and positively correlates with HIF‐1α expression. Moreover, elevated expression of ADAM23 was significantly correlated with poor overall survival. Collectively, our findings underscore ADAM23 as a critical metabolic‐neural linker that promotes HCC progression and drug resistance. These findings suggest that the ADAM23‐mediated neuron–tumor axis may represent a potential therapeutic target in aggressive HCC.
SN  - 0899-1987
SN  - 1098-2744
ER  -